查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1744783

全球机械循环支援设备市场

Mechanical Circulatory Support Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 284 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球机械循环支援设备市场规模将达到 14 亿美元

全球机械循环辅助装置市场规模预计在2024年为12亿美元，到2030年将达到14亿美元，在2024-2030年的分析期间内，复合年增长率为3.1%。心室辅助装置是本报告分析的细分市场之一，预计其复合年增长率为2.3%，到分析期结束时市场规模将达到6.48亿美元。体外膜氧气疗法细分市场在分析期间的复合年增长率估计为4.4%。

美国市场规模估计为 3.192 亿美元，而中国市场预计复合年增长率为 5.7%

美国机械循环支援设备市场规模预计在2024年达到3.192亿美元。作为世界第二大经济体，中国市场规模预计在2030年达到2.747亿美元，在分析期间（2024-2030年）的复合年增长率为5.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.3%和2.3%。在欧洲，预计德国市场的复合年增长率为1.7%。

全球机械循环支援设备市场－主要趋势与驱动因素摘要

为什么机械循环支持将彻底改变心臟衰竭治疗

机械循环支持 (MCS) 是一项挽救生命的技术，旨在支持或取代晚期心臟衰竭患者衰竭心臟的泵血功能。这些设备包括心室辅助装置 (VAD)、全人工心臟 (TAH) 和体外膜氧气疗法(ECMO) 系统，可作为移植前的过渡、復健前的过渡，或在药物治疗无效时作为目标导向治疗。 ECMO 在提高生存率、稳定危重患者病情以及改善等待心臟移植或治疗不可逆性心臟衰竭的患者的生活品质方面发挥着重要作用。

微型化、生物相容性和长期植入性等技术进步，扩大了 MCS 在不同年龄层和併发症患者的应用范围。对于合格移植的末期心臟衰竭患者，MCS 提供了一种可行的长期治疗方案，可维持循环功能并改善活动能力和独立性。人口老化以及心肌病导致的缺血性心臟疾病和心臟衰竭盛行率的上升，正在推动全球对 MCS 技术的临床需求。

工程进步和临床整合如何提高设备效用？

机械和材料工程领域的最新趋势正在推动下一代辅助人工心臟的开发，这些装置更小、更耐用，并且不易出现血栓症、出血和感染疾病等併发症。持续流动泵、磁浮和无线能量传输系统正在透过改善血流动力学稳定性并减轻手术负担来重新定义患者预后。穿戴式动力传动系统和完全植入式原型正在改善患者的活动能力和生活质量，促进门诊管理和长期使用。

临床上，即时血流动力学监测、远端遥测和人工智慧驱动数据解读的整合正在增强决策能力和植入后护理。由外科医生、循环系统和復健专家组成的多学科心臟衰竭团队，在先进的影像和风险分层工具的支持下，实施针对患者的客製化 MCS通讯协定。这些系统性改善缩短了住院时间，改善了復健效果，并使其在全球三级医疗中心日益广泛的应用。

哪些医疗机构和病患群体正在引领采用？

心胸外科中心、学术医院和晚期心臟衰竭计画是 MCS 设备的主要采用者。在心臟移植计画较为完善的美国、欧洲和日本，MCS 设备在移植前和移植后照护的使用正在增加。儿科心臟中心正在采用专为先天性心臟疾病和儿科心肌病设计的微型 MCS 系统，而新兴国家则在重症监护病房引入 ECMO 系统，用于治疗可逆性心臟衰竭和呼吸衰竭。

急诊和创伤治疗的需求也在增长，在这些情况下，可携式膜氧合 (ECMO) 装置被部署用于支持心臟麻痹患者并衔接关键干预措施。世界各地的心臟外科项目，尤其是高所得国家的心臟外科项目，正在加大对机械支持系统 (MCS) 的投资，将其作为心血管综合护理策略的一部分。随着心臟衰竭成为全球发病和死亡的主要原因，预计各种医疗保健机构对机械支援设备的需求都将增加。

机械循环支持市场的成长受到多种因素的推动…

机械循环支持市场的成长动力源于慢性和终末期心臟衰竭盛行率的不断上升、设备小型化的进步，以及辅助人工心臟和体外膜氧合（ECMO）在移植和重症加护中的临床应用日益增多。等待心臟移植的患者数量不断增加，加上捐赠器官的短缺，推动了对长期机械支持的需求。临床指引越来越多地推荐早期疗育，而改进的患者选择和出院后通讯协定也正在改善患者的预后。

对生物相容性材料、无线供电系统和完全植入式设备的投资正在推动创新，而医疗保健系统正在为心臟衰竭管理基础设施配置资源。儿科心臟病学和创伤护理领域的新兴应用也正在推动新的使用案例。此外，政府资助、FDA 早期临床试验资格认定以及产学研合作正在加速产品开发流程，确保 MCS 技术在全球市场的长期扩张。

部分

产品（辅助人工心臟输液设备、体外膜氧合器、主动脉内球囊帮浦、人工心臟）；最终用途（医院、心臟中心、门诊手术中心、专科中心）

受访公司范例（总合41家）

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • Braile Biomedica Ltd.
  • CardiacAssist, Inc.
  • CardioBridge GmbH
  • Carmat SA
  • Eurosets Srl
  • Getinge AB
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MicroMed Cardiovascular, Inc.
  • ReliantHeart, Inc.
  • St. Jude Medical, Inc.
  • Sun Medical Technology Research Corp.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Corporation

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）预测公司竞争地位的变化，我们的新报告也纳入了关税对地域市场的影响。这种复杂且多方面的市场动态预计将以人为提高销货成本、降低盈利、重组供应链等形式对竞争对手产生影响，并带来其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户也将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP35334

Global Mechanical Circulatory Support Devices Market to Reach US$1.4 Billion by 2030

The global market for Mechanical Circulatory Support Devices estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Ventricular Assist Devices, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$648.0 Million by the end of the analysis period. Growth in the Extracorporeal Membrane Oxygenation segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$319.2 Million While China is Forecast to Grow at 5.7% CAGR

The Mechanical Circulatory Support Devices market in the U.S. is estimated at US$319.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$274.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Mechanical Circulatory Support Devices Market - Key Trends & Drivers Summarized

Why Are Mechanical Circulatory Support Devices Revolutionizing Heart Failure Treatment?

Mechanical circulatory support (MCS) devices are life-saving technologies designed to support or replace the pumping function of the failing heart in patients with advanced heart failure. These devices-including ventricular assist devices (VADs), total artificial hearts (TAHs), and extracorporeal membrane oxygenation (ECMO) systems-are used as bridge-to-transplant, bridge-to-recovery, or destination therapy in cases where pharmacologic management is no longer sufficient. They play a crucial role in improving survival rates, stabilizing patients during critical periods, and enhancing quality of life for those awaiting cardiac transplants or managing irreversible cardiac decline.

Advances in miniaturization, biocompatibility, and long-term implantability have expanded the indications for MCS use across age groups and comorbidities. For end-stage heart failure patients ineligible for transplant, MCS devices offer a viable long-term treatment option that sustains circulatory function and improves mobility and independence. The increasing prevalence of heart failure due to aging populations, ischemic heart disease, and cardiomyopathies is driving the global clinical demand for MCS technologies.

How Are Engineering Advances and Clinical Integration Enhancing Device Utility?

Recent innovations in mechanical and materials engineering have led to the development of next-generation VADs that are smaller, more durable, and less prone to complications like thrombosis, bleeding, or infection. Continuous-flow pumps, magnetically levitated impellers, and wireless energy transfer systems are redefining patient outcomes by improving hemodynamic stability with reduced surgical burden. Wearable driveline systems and fully implantable prototypes are improving patient mobility and quality of life, facilitating outpatient management and long-term use.

On the clinical front, integration of real-time hemodynamic monitoring, remote telemetry, and AI-assisted data interpretation is enhancing decision-making and post-implantation care. Multidisciplinary heart failure teams, including surgeons, cardiologists, and rehabilitation specialists, are implementing patient-tailored MCS protocols supported by advanced imaging and risk stratification tools. These systemic improvements are reducing hospitalization time, improving recovery outcomes, and expanding adoption in tertiary care centers worldwide.

Which Healthcare Settings and Patient Segments Are Leading Adoption?

Cardiothoracic surgical centers, academic hospitals, and advanced heart failure programs are the primary adopters of MCS devices. In the U.S., Europe, and Japan, where cardiac transplant programs are well established, MCS devices are increasingly used as both pre-transplant and destination therapy. Pediatric cardiac centers are adopting miniaturized MCS systems designed for congenital heart disease and pediatric cardiomyopathies, while emerging economies are deploying ECMO systems in critical care units for reversible cardiac or respiratory failure.

Demand is also growing in emergency and trauma settings, where portable ECMO units are deployed to support cardiac arrest patients or bridge critical interventions. Global cardiac surgery programs, especially in high-income nations, are investing in MCS as part of integrated cardiovascular care strategies. As heart failure becomes a leading cause of morbidity and mortality worldwide, demand for mechanical support devices is expected to rise across a broad spectrum of care settings.

The Growth in the Mechanical Circulatory Support Devices Market Is Driven by Several Factors…

The growth in the mechanical circulatory support devices market is driven by increasing prevalence of chronic and end-stage heart failure, advances in device miniaturization, and expanded clinical adoption of VADs and ECMO in transplant and critical care. Rising numbers of patients awaiting heart transplants, coupled with donor organ shortages, are fueling demand for long-term mechanical support. Clinical guidelines are increasingly endorsing early intervention with MCS, while better patient selection and post-discharge protocols are improving outcomes.

Investments in biocompatible materials, wireless power systems, and fully implantable devices are driving innovation, while healthcare systems are allocating resources to heart failure management infrastructure. Emerging applications in pediatric cardiology and trauma care are also creating new use cases. Furthermore, government funding, FDA fast-track designations, and academic-industry partnerships are accelerating product development pipelines-ensuring long-term global market expansion for MCS technologies.

SCOPE OF STUDY:

The report analyzes the Mechanical Circulatory Support Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps, Artificial Heart); End-Use (Hospitals, Cardiology Centers, Ambulatory Surgery Centers, Specialty Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • Braile Biomedica Ltd.
  • CardiacAssist, Inc.
  • CardioBridge GmbH
  • Carmat SA
  • Eurosets S.r.l.
  • Getinge AB
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MicroMed Cardiovascular, Inc.
  • ReliantHeart, Inc.
  • St. Jude Medical, Inc.
  • Sun Medical Technology Research Corp.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Mechanical Circulatory Support Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of End-Stage Heart Failure Globally Drives Demand for Mechanical Circulatory Support (MCS) Devices
    • Growing Preference for Ventricular Assist Devices (VADs) as Bridge-to-Transplant Solutions Expands Clinical Adoption
    • Advancements in Miniaturization and Wireless Power Transfer Strengthen the Case for Next-Generation Implantable MCS Systems
    • Improved Patient Survival Rates With Long-Term LVAD Use Encourage Wider Use in Destination Therapy Applications
    • Expansion of Advanced Heart Failure Programs in Hospitals Boosts Institutional Investment in MCS Infrastructure
    • Rising Number of Heart Transplant Candidates Highlights Demand for Durable Bridge-to-Transplant Support Systems
    • OEM Focus on Fully Implantable and Percutaneous Systems Enhances Patient Mobility and Reduces Infection Risks
    • Integration of Remote Monitoring and Telehealth Capabilities Supports Post-Implant Management and Reduces Readmissions
    • Government Reimbursement Policies and Public Health Coverage Expand Patient Access to MCS Devices in Developed Markets
    • Clinical Research Demonstrating Improved Quality of Life Fuels Physician Confidence in Prescribing MCS Therapies
    • Increasing Use of MCS in Pediatric and Congenital Heart Disease Applications Creates New Niche Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mechanical Circulatory Support Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mechanical Circulatory Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Ventricular Assist Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Extracorporeal Membrane Oxygenation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Extracorporeal Membrane Oxygenation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Intra-Aortic Balloon Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Intra-Aortic Balloon Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Intra-Aortic Balloon Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiology Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Specialty Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Specialty Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Specialty Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Mechanical Circulatory Support Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030

IV. COMPETITION